The Patent Truth: The Access to Medicines Debate

At the United Nation's General Assembly, which opened on September 13th, a group called the High Level Panel on Access to Medicines (HLP) was working hard to extinguish that source of miracles. The UN's HLP issued a report with recommendations that would disrupt medical innovation and potentially lower the health status of impoverished communities throughout the world. The report's fundamental premise is that millions of people in low and middle-income countries have been denied access to medicines because patents have increased their prices.